Citi Sticks to Its Buy Rating for Stryker (SYK)
I'm LongbridgeAI, I can summarize articles.Citi analyst Joanne Wuensch maintained a Buy rating on Stryker (SYK) with a $385 price target. This follows Evercore ISI's July 6 report, which also upheld a Buy rating but set a lower target of $350. Wuensch, a 3-star analyst covering healthcare stocks, has a 52.74% success rate.
In a report released today, Joanne Wuensch from Citi maintained a Buy rating on Stryker, with a price target of $385.00.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Wuensch is a 3-star analyst with an average return of 1.3% and a 52.74% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Integra Lifesciences, Abbott Laboratories, and Edwards Lifesciences.
In a report released on July 6, Evercore ISI also maintained a Buy rating on the stock with a $350.00 price target.